Stockreport

Pulmatrix Announces Peer-Reviewed Publication of Clinical Results for its Orally Inhaled DHE for Acute Migraine (PUR3100) [Yahoo! Finance]

Pulmatrix, Inc.  (PULM) 
Last pulmatrix, inc. earnings: 8/5 09:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.pulmatrix.com
PDF Self-administered PUR3100 showed improved safety and tolerability relative to IV DHE. Pulmatrix previously received FDA's acceptance of an IND application and a "stud [Read more]